In Type 2 Diabetes Adding Semaglutide to SGLT2 Inhibitor Improves Glycemic Control
In Type 2 Diabetes, Adding Semaglutide to SGLT2 Inhibitor Improves Glycemic Control
19:44 EST 3 Mar 2019 |
NEJM
Adding semaglutide — a glucagon-like peptide-1 (GLP-1) receptor agonist — to a sodium glucose cotransporter-2 (SGLT2) inhibitor improves glycemic control in patients with...
More From BioPortfolio on "In Type 2 Diabetes, Adding Semaglutide to SGLT2 Inhibitor Improves Glycemic Control"